Interviews with young adults with acute leukemia reveals their strategies for coping with induction therapy can be categorized into 3 themes.
A retrospective study using a cohort of the ALiCCS Study sought to determine hospitalization risks among survivors of leukemia during childhood 20 years after diagnosis.
Researchers present data on the efficacy and safety of decitabine in older patients with acute myeloid leukemia.
A data analysis revealed a genetic predictor of relapse for pediatric patients with ALL.
Researchers sought to determine the association between chemotherapy, particularly platinum-based agents, and increased risk of tMDS/AML.